日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Total neoadjuvant chemotherapy combined with PD‑1 blockade and IL‑2 in MSS/pMMR locally advanced rectal cancer: short-term results of a prospective, single-arm phase II study

新辅助化疗联合PD-1阻断剂和IL-2治疗MSS/pMMR局部晚期直肠癌:一项前瞻性单臂II期研究的短期结果

Tang, Junwei; Wang, Lu; Yang, Sheng; Peng, Wen; Zhang, Yi; Zhang, Yue; Jin, Kangpeng; Wang, Xiaowei; Feng, Yifei; Sun, Yueming

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial

低剂量IL-2抗炎疗法治疗急性冠脉综合征:一项随机II期试验

Sriranjan-Rothwell, Rouchelle S; Zhao, Tian X; Hoole, Stephen P; Bond, Simon J; Tarkin, Jason M; Brubert, Jacob; Hubsch, Annette; Helmy, Joanna; Bumanlag-Amis, Elaine; Jalaludeen, Navazh; Templin, Heike; Jiang, Wei; Tedgui, Alain; Zhao, Xiaohui; Nus, Meritxell; Warnes, Victoria; Krishnan, Unni; O'Brien, James W; Wall, Christopher; Rudd, James H F; Cheriyan, Joseph; Mallat, Ziad

Cell cycle arrest enhances CD8(+) T cell effector function by potentiating glucose metabolism and IL-2 signaling.

细胞周期阻滞通过增强葡萄糖代谢和IL-2信号传导来增强CD8(+) T细胞效应功能。

van Haften Floortje J, van der Sluis Tetje C, Hepp Hanna S, Mülling Nils, Nadafi Reza, Sampadi Bharath, van Duikeren Suzanne, Mostert J Shirin, van der Sterre Rosemarijn, van Veelen Peter A, Heieis Graham A, Veerkamp Dominique M B, Wesselink Thomas H, Vleeshouwers Ward, Beijnes Macha, Pardieck Iris N, van Horssen Eralin L F, de Groot Anne F, van der Ploeg Manon, Kroep Judith R, de Miranda Noel F C C, van der Zanden Sabina Y, Neefjes Jacques, Mei Hailiang, Vertegaal Alfred C O, Everts Bart, van der Burg Sjoerd H, Arens Ramon

Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells

细胞类型特异性增强子调控先天性和适应性3型淋巴细胞中IL-22的表达。

Saini, Ankita; Hopkins, Leone S; Serna, Vanida A; McCullen, Matthew V D; Selner, Nicholas G; Bhattarai, Bishan; Fachi, José L; Glynn, Rebecca A; Hayer, Katharina E; Bassing, Craig H; Colonna, Marco; Oltz, Eugene M

Reframing IL-27: a central regulator of CD8(+) T cell immunity

重新定义IL-27:CD8(+) T细胞免疫的核心调节因子

Venzin, Valentina; Iannacone, Matteo

In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis

利用基因工程改造的IL-2突变体在体内扩增调节性T细胞以抑制自身免疫性肾小球肾炎

Kuang, Huang; Lin, Cai-Xia; Huang, Jing; Li, Wen-Xuan; Zhu, Yu-Ge; Jiang, Nan; Li, Zhong; Li, Nan; Li, Ping; Jia, Xiao-Yu; Cui, Zhao; Zhao, Ming-Hui

IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cells.

IL-7/IL-15/IL-21 细胞因子融合支架可生成富含长寿命 T 记忆干细胞的高功能 CAR T 细胞。

Single-chain IL-23 secretion by CAR-T cells improves tumor control and persistence against solid tumors

CAR-T细胞分泌的单链IL-23可改善肿瘤控制并增强对实体瘤的持久性

Keane, John T; Degaramo, David A; Sosnoski, Heather M; Brookens, Shawna K; Lewis, Hyeon-Gyu S; Liu, Fang; Posey, Avery D Jr

Distinct Roles of IL-4, IL-13, and IL-22 in Human Skin Barrier Dysfunction and Atopic Dermatitis.

IL-4、IL-13 和 IL-22 在人类皮肤屏障功能障碍和特应性皮炎中的不同作用。

D'Avino Paolo, Kim Juno, Li Manru, Gessner Philipp, Westermann Patrick, Pat Yagız, Beha Carina, Traidl-Hoffmann Claudia, Bost Jeremy, Gaudenzio Nicolas, Messner Christoph B, Akdis Cezmi A, Mitamura Yasutaka

Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation

低剂量IL-2用于单倍体相合干细胞移植后移植物抗宿主病预防

Xu, Zheng-Li; Lv, Meng; Yu, Xing-Xing; Ding, Yi-Yang; Han, Ting-Ting; Fu, Hai-Xia; Zhang, Yuan-Yuan; Mo, Xiao-Dong; Sun, Yu-Qian; Xu, Lan-Ping; Zhang, Xiao-Hui; Wang, Yu; Huang, Xiao-Jun; Zhao, Xiang-Yu